Institute for Health Metrics and Evaluation

The Institute for Health Metrics and Evaluation (IHME) is an independent global health research center at the University of Washington that provides rigorous and comparable measurement of the world's most important health problems and evaluates the strategies used to address them. IHME makes this information freely available so that policymakers have the evidence they need to make informed decisions about how to allocate resources to best improve population health.

すべてのデータセット: G H
  • G
    • GBD 2017 - Health-related Sustainable Development Goals (SDG) Indicators 1990-2030
      3月 2019
      ソース： Institute for Health Metrics and Evaluation
      アップロード者： Knoema
      以下でアクセス： 29 8月, 2019
      データセットを選択
      Data cited at: Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2017) Health-related Sustainable Development Goals (SDG) Indicators 1990-2030. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2018.   The Global Burden of Disease Study 2017 (GBD 2017), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors from 1990 to 2017. The United Nations established, in September 2015, the Sustainable Development Goals (SDGs), which specify 17 universal goals, 169 targets, and 232 indicators leading up to 2030. Drawing from GBD 2017, this dataset provides estimates on progress for 41 health-related SDG indicators for 195 countries and territories from 1990 to 2017, and projections, based on past trends, for 2018 to 2030. Estimates are also included for the health-related SDG index, a summary measure of overall performance across the health-related SDGs.
  • H
    • Healthcare Access and Quality Index Based on Amenable Mortality 1990-2016
      12月 2018
      ソース： Institute for Health Metrics and Evaluation
      アップロード者： Knoema
      以下でアクセス： 26 12月, 2018
      データセットを選択
      Global Burden of Disease Study 2016 (GBD 2016) Healthcare Access and Quality Index Based on Amenable Mortality 1990–2016. Global Burden of Disease Study 2016 (GBD 2016) estimates were used in an analysis of personal healthcare access and quality for 195 countries and territories, as well as selected subnational locations, over time. This dataset includes the following global, regional, national, and selected subnational estimates for 1990-2016: age-standardized risk-standardized death rates from 24 non-cancer causes considered amenable to healthcare; age-standardized mortality-to-incidence ratios for 8 cancers considered amenable to healthcare; and the Healthcare Access and Quality (HAQ) Index and individual scores for each of the 32 causes on a scale of 0 to 100. Code used to produce the estimates is also included. Results were published in The Lancet in May 2018 in "Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016